78 related articles for article (PubMed ID: 16981962)
1. Magnetic resonance imaging to evaluate NASHA/Dx gel (Zuidex) for stress urinary incontinence.
Fianu-Jonasson A; Edwall L; Wiberg MK
Int J Clin Pract; 2006 Oct; 60(10):1181-6. PubMed ID: 16981962
[TBL] [Abstract][Full Text] [Related]
2. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence.
Chapple CR; Haab F; Cervigni M; Dannecker C; Fianu-Jonasson A; Sultan AH
Eur Urol; 2005 Sep; 48(3):488-94. PubMed ID: 15967568
[TBL] [Abstract][Full Text] [Related]
3. Treatment of stress urinary incontinence with non-animal stabilised hyaluronic acid/dextranomer (NASHA/Dx) gel : An analysis of utility and cost.
Kobelt G; Fianu-Jonasson A
Clin Drug Investig; 2006; 26(10):583-91. PubMed ID: 17163292
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence.
van Kerrebroeck P; ter Meulen F; Larsson G; Farrelly E; Edwall L; Fianu-Jonasson A
Urology; 2004 Aug; 64(2):276-81. PubMed ID: 15302478
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of dextranomer in stabilized hyaluronic acid (NASHA/Dx) for treatment of faecal incontinence.
La Torre F; de la Portilla F
Colorectal Dis; 2013 May; 15(5):569-74. PubMed ID: 23374680
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of transurethral injection of hyaluronic acid/dextranomer (NASHA/Dx gel) for the treatment of stress urinary incontinence (SUI).
Lone F; Sultan AH; Thakar R
Int Urogynecol J; 2010 Nov; 21(11):1359-64. PubMed ID: 20571764
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial.
Graf W; Mellgren A; Matzel KE; Hull T; Johansson C; Bernstein M;
Lancet; 2011 Mar; 377(9770):997-1003. PubMed ID: 21420555
[TBL] [Abstract][Full Text] [Related]
8. Three-year cost-effectiveness model for non-animal stabilized hyaluronic acid and dextranomer copolymer compared with sacral nerve stimulation after conservative therapy for the management of fecal incontinence.
Bernstein MA; Purdy CH; Becker A; Magar R
Clin Ther; 2014 Jun; 36(6):890-905.e3. PubMed ID: 24815061
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence.
Mellgren A; Matzel KE; Pollack J; Hull T; Bernstein M; Graf W;
Neurogastroenterol Motil; 2014 Aug; 26(8):1087-94. PubMed ID: 24837493
[TBL] [Abstract][Full Text] [Related]
10. Canine bladder tissue responses to injectable stabilized non-animal hyaluronic acid/dextranomer (NASHA/Dx) gel.
Olson ME; Hjelm R
Eur J Obstet Gynecol Reprod Biol; 2008 May; 138(1):114-5. PubMed ID: 17482338
[No Abstract] [Full Text] [Related]
11. [Intraurethral injections of Zuidex: evaluation of the morbidity of the technique in the treatment of female urinary incontinence].
Ferchaud J; Girard F; Ciofu C; Peyrat L; Haab F
Prog Urol; 2005 Jun; 15(3):494-7. PubMed ID: 16097156
[TBL] [Abstract][Full Text] [Related]
12. Submucosal injection of stabilized nonanimal hyaluronic acid with dextranomer: a new treatment option for fecal incontinence.
Danielson J; Karlbom U; Sonesson AC; Wester T; Graf W
Dis Colon Rectum; 2009 Jun; 52(6):1101-6. PubMed ID: 19581853
[TBL] [Abstract][Full Text] [Related]
13. [Paraurethral abscess developing after mid-urethral Zuidex-injection in women with stress urinary incontinence -- management of complications and retrospective comparison with bladder neck located injection technique].
Hagemeier T; Blau U; Gauruder-Burmester A; Tunn R
Zentralbl Gynakol; 2006 Apr; 128(2):68-70. PubMed ID: 16673247
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and quality of life 2 years after treatment for faecal incontinence with injectable bulking agents.
Danielson J; Karlbom U; Wester T; Graf W
Tech Coloproctol; 2013 Aug; 17(4):389-95. PubMed ID: 23224913
[TBL] [Abstract][Full Text] [Related]
15. Urethrovaginal fistula associated with 'sterile abscess' formation following periurethral injection of dextranomer/hyaluronic acid co-polymer (Zuidex) for the treatment of stress urinary incontinence--a case report.
Hilton P
BJOG; 2009 Oct; 116(11):1527-30. PubMed ID: 19681847
[No Abstract] [Full Text] [Related]
16. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically.
Lightner D; Rovner E; Corcos J; Payne C; Brubaker L; Drutz H; Steinhoff G;
Urology; 2009 Oct; 74(4):771-5. PubMed ID: 19660800
[TBL] [Abstract][Full Text] [Related]
17. Treatment of stress urinary incontinence using a copolymer system: impact on quality of life.
van Kerrebroeck P; ter Meulen F; Larsson G; Farrelly E; Edwall L; Fianu-Jonasson A
BJU Int; 2004 Nov; 94(7):1040-3. PubMed ID: 15541124
[TBL] [Abstract][Full Text] [Related]
18. Injectable bulking treatment of persistent fecal incontinence in adult patients after anorectal malformations.
Danielson J; Karlbom U; Wester T; Graf W
J Pediatr Surg; 2020 Mar; 55(3):397-402. PubMed ID: 31493885
[TBL] [Abstract][Full Text] [Related]
19. First paediatric experience of a new device for "non-endoscopic" periurethral injection in urinary incontinence.
Capozza N; De Dominicis M; Collura G; Caione P
Pediatr Surg Int; 2005 Sep; 21(9):770-2. PubMed ID: 16142485
[TBL] [Abstract][Full Text] [Related]
20. [Periurethral pseudocysts following urethral injections of Zuidex: review of the literature].
Loisel C; Secco M; Rocher-Barrat A; Caremel R; Grise P
Prog Urol; 2008 Dec; 18(13):1038-43. PubMed ID: 19041807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
